Pharmacokinetics of Ertugliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor (SGLT2i) in Horses After Enteral Administration

Ertugliflozin is a sodium-glucose co-transporter-2 inhibitor that has demonstrated promise as a treatment for hyperinsulinaemia in horses. Despite the frequent use of ertugliflozin in equine clinical practice, the pharmacokinetics of this drug in horses has not been established. The aim of the prese...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Naomi C. Kirkwood, Kristopher J. Hughes, Amy L. Lovett, Gregory S. Doran, David I. Rendle, Scott H. Edwards
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-05-01
coleção:	Veterinary Sciences
Assuntos:	equine metabolic syndrome (EMS) laminitis equine horse pituitary pars intermedia dysfunction (PPID) pharmacodynamics
Acesso em linha:	https://www.mdpi.com/2306-7381/13/5/445
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!